BigHat Biosciences

Developer of therapeutic human monoclonal antibodies designed to offer treatment of cancer and infectious diseases. The company's human monoclonal antibodies and antibody discovery platform couples proprietary knowledge of B cell immortalization with the isolation of promising antibodies from humans or animals, enabling healthcare organizations to provide patients with quality care in a cost-efficient manner.

Operator of advanced biopharmaceutical manufacturing company intended to change the way medicine is produced. The company offers a broad mix of customized manufacturing capabilities to serve the requirements of biopharmaceuticals at all stages of the drug development process - from pre-clinical development to commercial supply, thereby offering clients customized and scalable processes, with high-quality and regulatory capability, facilities for complex and novel medicines.

Developer of polymeric therapeutics and vaccines designed to meet medical needs. The company focuses on amplifying the impact of vaccines and therapeutics by using its self-amplifying ribonucleic acid platform to provide enhanced protein expression, combining tolerability with slow release and thermostability, enabling patients to get treatment for rare diseases.